Australia markets open in 9 hours 26 minutes

Medexus Pharmaceuticals Inc (P731.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
1.1200+0.0200 (+1.82%)
As of 04:10PM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Total revenue
115,725
108,096
76,701
79,660
55,506
Cost of revenue
54,499
48,058
38,774
37,655
24,364
Gross profit
61,226
60,038
37,927
42,005
31,142
Operating expenses
Research development
8,532
9,032
11,309
9,338
5,120
Selling general and administrative
39,646
42,164
38,596
31,430
26,680
Total operating expenses
48,437
51,549
50,303
41,274
32,277
Operating income or loss
12,789
8,489
-12,376
731
-1,135
Interest expense
14,752
13,606
12,223
9,816
6,867
Total other income/expenses net
1,091
76
20,779
-22,416
2,237
Income before tax
-872
-5,041
-3,820
-31,501
-5,545
Income tax expense
-6,752
-6,262
-941
-3,237
-844
Income from continuing operations
5,880
1,221
-2,879
-28,264
-4,701
Net income
5,880
1,221
-2,879
-28,264
-4,701
Net income available to common shareholders
5,880
1,221
-2,879
-28,264
-4,701
Basic EPS
0.25
0.06
-0.15
-1.86
-0.33
Diluted EPS
0.25
0.06
-0.15
-1.86
-0.33
Basic average shares
20,160
19,976
19,454
15,197
14,360
Diluted average shares
20,708
20,524
19,856
15,197
14,360